Advanced search
Publication Cover
Expert Opinion on Drug Discovery Volume 15, 2020 - Issue 2
Submit an article Journal homepage
395
Views
12
CrossRef citations to date
0
Altmetric
Review

Emerging opportunities of exploiting mycobacterial electron transport chain pathway for drug-resistant tuberculosis drug discovery

Kuldeep K. RoyDepartment of Pharmacoinformatics, National Institute of Pharmaceutical Education and Research (NIPER), Kolkata, IndiaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-9623-0617View further author information
ORCID Icon &
Mushtaq Ahmad WaniDepartment of Pharmacoinformatics, National Institute of Pharmaceutical Education and Research (NIPER), Kolkata, IndiaView further author information
Pages 231-241 | Received 30 Apr 2019, Accepted 20 Nov 2019, Published online: 27 Nov 2019

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Yiding Geng, Yongfang Xu, Mingxia Zhao, Xue Cao & Yixia Gong. (2023) Synthesis crystal structure, and DFT study of ethyl 2-ethylimidazo[1,2-a]pyridine-3-carboxylate. Molecular Crystals and Liquid Crystals 753:1, pages 88-97.
Read now

Articles from other publishers (11)

Lakshmi Mounika Kelam, Mushtaq Ahmad Wani & Devendra K. Dhaked. (2023) An update on ATP synthase inhibitors: A unique target for drug development in M. tuberculosis. Progress in Biophysics and Molecular Biology 180-181, pages 87-104.
Crossref
Rita Capela, Rita Félix, Marta Clariano, Diogo Nunes, Maria de Jesus Perry & Francisca Lopes. (2023) Target Identification in Anti-Tuberculosis Drug Discovery. International Journal of Molecular Sciences 24:13, pages 10482.
Crossref
Mohd. Imran, Abida, Nawaf M. Alotaibi, Hamdy K. Thabet, Jamal A. Alruwaili, Syed M.B. Asdaq, Lina Eltaib, Ahmed Alshehri, Ahad A. Alsaiari, Mazen Almehmadi, Amal B. Hommod Alshammari & Abdulmajeed M. Alshammari. (2023) QcrB inhibition as a potential approach for the treatment of tuberculosis: A review of recent developments, patents, and future directions. Journal of Infection and Public Health 16:6, pages 928-937.
Crossref
Gautam Kumar & Shobhna Kapoor. (2023) Targeting mycobacterial membranes and membrane proteins: Progress and limitations. Bioorganic & Medicinal Chemistry 81, pages 117212.
Crossref
Eugene V. Radchenko, Grigory V. Antonyan, Stanislav K. Ignatov & Vladimir A. Palyulin. (2023) Machine Learning Prediction of Mycobacterial Cell Wall Permeability of Drugs and Drug-like Compounds. Molecules 28:2, pages 633.
Crossref
Anna Clara Milesi Galdino, Mylene Vaillancourt, Diana Celedonio & Peter Jorth. 2023. Multispecies Biofilms. Multispecies Biofilms 231 267 .
Mushtaq Ahmad Wani & Devendra Kumar Dhaked. (2021) Targeting the cytochrome bc1 complex for drug development in M. tuberculosis: review. Molecular Diversity 26:5, pages 2949-2965.
Crossref
Ameya D. Bendre, Peter J. Peters & Janesh Kumar. (2021) Recent Insights into the Structure and Function of Mycobacterial Membrane Proteins Facilitated by Cryo-EM. The Journal of Membrane Biology 254:3, pages 321-341.
Crossref
Dörte Falke, Marco Fischer, Christian Ihling, Claudia Hammerschmidt, Andrea Sinz & Gary Sawers. (2021) Co‐purification of nitrate reductase 1 with components of the cytochrome bcc‐aa 3 oxidase supercomplex from spores of Streptomyces coelicolor A3(2) . FEBS Open Bio 11:3, pages 652-669.
Crossref
Milan Urban, Veronika Šlachtová & Lucie Brulíková. (2021) Small organic molecules targeting the energy metabolism of Mycobacterium tuberculosis. European Journal of Medicinal Chemistry 212, pages 113139.
Crossref
Balachandra Bandodkar, Radha Krishan Shandil, Jagadeesh Bhat & Tanjore S. Balganesh. (2020) Two Decades of TB Drug Discovery Efforts—What Have We Learned?. Applied Sciences 10:16, pages 5704.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.